Results for tag: "Protein Vaccine"

The Protein Vaccine market is a subset of the Proteomics industry, which focuses on the study of proteins and their functions. Protein Vaccines are a type of vaccine that use proteins to stimulate an immune response in the body. These vaccines are typically used to prevent infectious diseases, such as influenza, hepatitis, and measles. Protein Vaccines are typically produced using recombinant DNA technology, which involves the insertion of a gene into a host organism to produce a desired protein. The Protein Vaccine market is driven by the increasing prevalence of infectious diseases, as well as the growing demand for safe and effective vaccines. Additionally, advances in technology have enabled the development of more efficient and cost-effective production methods. Notable companies in the Protein Vaccine market include GlaxoSmithKline, Merck & Co., Sanofi, Pfizer, and Novavax. Show Less Read more